Bone Morphogenic Proteins and Their Antagonists in the Lower Airways of Stable COPD Patients
Authors:
- Antonino Di StefanoASAntonino Di Stefano
- Umberto RosaniUmberto Rosani
- Stefano LevraSLStefano Levra
- Isabella GnemmiIGIsabella Gnemmi
- Paola BrunPBPaola Brun
- Mauro ManiscalcoMauro Maniscalco
- Silvestro Ennio D’annaSDSilvestro Ennio D’anna
- Vitina CarrieroVCVitina Carriero
- Francesca BertoliniFBFrancesca Bertolini
- Fabio L. M. RicciardoloFRFabio L. M. Ricciardolo
Open Access
Abstract
Background: Bone morphogenic proteins (BMPs) and their antagonists are involved in the tissue development and homeostasis of various organs. Objective: To determine transcriptomic and protein expression of BMPs and their antagonists in stable COPD. Methods: We measured the expression and localization of BMPs and some relevant antagonists in bronchial biopsies of stable mild/moderate COPD (MCOPD) (n = 18), severe/very severe COPD (SCOPD) (n = 16), control smokers (CS) (n = 13), and control non-smokers (CNS) (n = 11), and in lung parenchyma of MCOPD (n = 9), CS (n = 11), and CNS (n = 9) using immunohistochemistry and transcriptome analysis, in vitro after the stimulation of the 16HBE cells. Results: In bronchial biopsies, BMP4 antagonists CRIM1 and chordin were increased in the bronchial epithelium and lamina propria of COPD patients. BMP4 expression was decreased in the bronchial epithelium of SCOPD and MCOPD compared to CNS. Lung transcriptomic data showed non-significant changes between groups. CRIM1 and chordin were significantly decreased in the alveolar macrophages and alveolar septa in COPD patients. External 16HBE treatment with BMP4 protein reduced the bronchial epithelial cell proliferation. Conclusions: These data show an imbalance between BMP proteins and their antagonists in the lungs of stable COPD. This imbalance may play a role in the remodeling of the airways, altering the regenerative–reparative responses of the diseased bronchioles and lung parenchyma.Keywords
This publication has 41 references indexed in Scilit:
- Bone morphogenetic proteins enhance an epithelial-mesenchymal transition in normal airway epithelial cells during restitution of a disrupted epitheliumRespiratory Research, 2013
- Antagonism and synergy between extracellular BMP modulators Tsg and BMPER to balance blood vessel formationJournal of Cell Science, 2013
- Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progressionNature Medicine, 2012
- Preferential Activation of SMAD1/5/8 on the Fibrosa Endothelium in Calcified Human Aortic Valves - Association with Low BMP Antagonists and SMAD6PLOS ONE, 2011
- Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonistsBiochemical Journal, 2010
- BMPER Is Upregulated by Statins and Modulates Endothelial Inflammation by Intercellular Adhesion Molecule–1Arteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Micro–Computed Tomography Measurements of Peripheral Lung Pathology in Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2009
- Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPDThorax, 2009
- A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signalingJournal of Cell Biology, 2009
- Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of ChordinJournal of Biological Chemistry, 2004